Ferroptosis and its emerging roles in cardiovascular diseases

Pharmacol Res. 2021 Apr:166:105466. doi: 10.1016/j.phrs.2021.105466. Epub 2021 Feb 3.

Abstract

Ferroptosis is a new form of regulated cell death (RCD) driven by iron-dependent lipid peroxidation, which is morphologically and mechanistically distinct from other forms of RCD including apoptosis, autophagic cell death, pyroptosis and necroptosis. Recently, ferroptosis has been found to participate in the development of various cardiovascular diseases (CVDs) including doxorubicin-induced cardiotoxicity, ischemia/reperfusion-induced cardiomyopathy, heart failure, aortic dissection and stroke. Cardiovascular homeostasis is indulged in delicate equilibrium of assorted cell types composing the heart or vessels, and how ferroptosis contributes to the pathophysiological responses in CVD progression is unclear. Herein, we reviewed recent discoveries on the basis of ferroptosis and its involvement in CVD pathogenesis, together with related therapeutic potentials, aiming to provide insights on fundamental mechanisms of ferroptosis and implications in CVDs and associated disorders.

Keywords: Cardiovascular disease; Ferroptosis; Iron; Lipid peroxidation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology*
  • Drug Discovery
  • Ferroptosis* / drug effects
  • Humans
  • Iron / metabolism
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use
  • Lipid Peroxidation / drug effects

Substances

  • Cardiotonic Agents
  • Iron Chelating Agents
  • Iron